ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer (GBM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00045968
Recruitment Status : Active, not recruiting
First Posted : September 19, 2002
Last Update Posted : October 14, 2016
Sponsor:
Information provided by (Responsible Party):
Northwest Biotherapeutics